Phreesia Bundle
Who Really Owns Phreesia?
Understanding the Phreesia SWOT Analysis is key to grasping its potential, but have you ever wondered about the driving forces behind this healthcare tech innovator? Knowing who owns Phreesia is critical for anyone looking to understand its long-term strategy and financial health. From its inception to its current status as a publicly traded company, Phreesia's ownership has evolved significantly.
This article will explore the Phreesia ownership structure, including the influence of Phreesia investors and the roles of Phreesia executives. We'll examine the shift from private to public ownership following its IPO, providing insights into the key players shaping the company's future. Analyzing Phreesia stock and its performance offers a deeper understanding of the company's trajectory and its position within the healthcare IT industry. Discover the answers to "Who owns Phreesia" and gain valuable insights into this dynamic company.
Who Founded Phreesia?
The story of Phreesia's ownership begins with its co-founding in January 2005 by Chaim Indig and Evan Roberts. Understanding the evolution of Phreesia ownership is key to grasping its journey from a startup to a publicly traded company. The company's early structure and the influence of its founders and initial investors set the stage for its future growth.
Chaim Indig, as CEO and a board member, and Evan Roberts, as COO, have been central to the company's strategic direction since its inception. Michael Weintraub, the Founding Chair of the board, also played a pivotal role in the early governance of the company. The leadership team's commitment has been crucial in shaping the company's trajectory and its impact on the healthcare sector.
While the precise initial equity distribution is not publicly available, the continued involvement of Indig, Roberts, and Weintraub indicates their significant stake and influence in the company. Their roles highlight the importance of founder leadership in driving the company's vision and operational excellence, making them key figures in understanding who owns Phreesia.
Before becoming a public entity, the company secured $109 million across nine funding rounds. Early investors like Polaris Partners, Sandbox Industries, and LLR Partners were instrumental in providing the capital needed for growth and expansion. These early investors played a crucial role in the company's initial success.
- Polaris Partners, Sandbox Industries, and LLR Partners provided crucial early funding.
- These investments supported the development of the platform and expansion of its reach.
- Early funding rounds were essential for building the company's infrastructure.
- The involvement of these investors shaped the company's early strategic direction.
Phreesia SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Phreesia’s Ownership Changed Over Time?
The path of Phreesia's ownership has changed significantly since its Initial Public Offering (IPO) on July 18, 2019. The company, now traded on the New York Stock Exchange (NYSE) under the ticker symbol PHR, has transitioned from private ownership to a structure dominated by institutional investors. This shift has been a key aspect of its growth and market presence.
As of May 2025, the ownership structure of Phreesia is heavily influenced by institutional investors, who hold approximately 98.00% of the shares. This widespread institutional backing reflects confidence in the company's potential and strategic direction. With 58,772,448 shares of common stock outstanding as of March 7, 2025, the distribution among these investors is a critical factor in the company's stability and market performance. Understanding who owns Phreesia is essential for anyone looking at its stock.
| Shareholder | Shares Held (May 2025) | Percentage of Shares |
|---|---|---|
| Fmr Llc | Data Not Available | Data Not Available |
| BlackRock, Inc. | Data Not Available | Data Not Available |
| Vanguard Group Inc | Data Not Available | Data Not Available |
Key institutional shareholders as of May 2025 include Fmr Llc, BlackRock, Inc., and Vanguard Group Inc. Other significant holders include Brown Advisory Inc, Greenhouse Funds LLLP, Champlain Investment Partners, LLC, SMCWX - SMALLCAP WORLD FUND INC Class A, Capital International Investors, and UBS Asset Management Americas Inc. Mutual funds collectively hold approximately 74.54% of the shares as of May 2025, highlighting the broad-based investment in the company. The concentration of institutional shareholding is reported at 4.78%. These details are crucial for those tracking Phreesia's stock and the interests of its Phreesia investors.
Changes in institutional holdings show the dynamic nature of Phreesia's ownership. In Q1 2025, UBS AM, a business unit of UBS Asset Management Americas LLC, increased its portfolio by adding 1,377,904 shares (+108.7%), while Brown Advisory Inc. removed 1,824,110 shares (-32.6%).
- Institutional investors hold approximately 98.00% of Phreesia's shares.
- Mutual funds hold approximately 74.54% of the shares.
- Understanding the Phreesia company ownership structure is key for investors.
- For more insights, check out the Marketing Strategy of Phreesia.
Phreesia PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Phreesia’s Board?
The Board of Directors is pivotal in guiding the strategic direction and governance of the company, acting on behalf of its shareholders. The board is composed of both founding members and independent directors. Key figures on the board include Michael Weintraub, the Founding Chair, Chaim Indig, who serves as the Chief Executive Officer and a board member, and Evan Roberts, the Chief Operating Officer. Additional board members include Edward L. Cahill, Lainie Goldstein, Gillian Munson, Mark Smith, M.D., Ramin Sayar, and Lisa Egbuonu-Davis, M.D., MPH, MBA.
The composition of the board reflects a blend of experience and perspectives, crucial for navigating the healthcare technology landscape. This structure ensures a balance between the vision of the founders and the oversight of independent directors, supporting sound corporate governance and strategic decision-making. Understanding the board's composition is essential for anyone looking into Revenue Streams & Business Model of Phreesia.
| Board Member | Title | Key Role |
|---|---|---|
| Michael Weintraub | Founding Chair | Provides strategic guidance and oversight. |
| Chaim Indig | Chief Executive Officer and Board Member | Leads the company's operations and strategy. |
| Evan Roberts | Chief Operating Officer | Oversees operational efficiency and execution. |
| Edward L. Cahill | Board Member | Offers independent oversight and expertise. |
| Lainie Goldstein | Board Member | Offers independent oversight and expertise. |
| Gillian Munson | Board Member | Offers independent oversight and expertise. |
| Mark Smith, M.D. | Board Member | Offers independent oversight and expertise. |
| Ramin Sayar | Board Member | Offers independent oversight and expertise. |
| Lisa Egbuonu-Davis, M.D., MPH, MBA | Board Member | Offers independent oversight and expertise. |
The voting structure for the company's common stock is generally one-share-one-vote. As of May 1, 2024, the record date for the 2024 Annual Meeting of Stockholders, there were 57,319,811 shares of common stock outstanding. Stockholders are not permitted to cumulate votes for director elections. As of May 2025, insiders have slightly increased their holdings from 8.63% to 8.66%.
Understanding who owns the company is crucial for investors and stakeholders.
- The board includes founders and independent members, ensuring diverse perspectives.
- The voting structure is straightforward, with one-share-one-vote.
- Insiders hold a notable stake, indicating alignment with the company's success.
- Institutional investors hold the majority of the shares.
Phreesia Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Phreesia’s Ownership Landscape?
Over the past few years, the ownership structure of the company has seen ongoing evolution. As of January 31, 2025, the company reported a total revenue of $419.8 million, which is an 18% increase year-over-year. The company facilitated roughly 170 million patient visits in 2024, which is about 1 in 7 visits across the U.S. This growth and operational scale are key factors influencing the company's ownership dynamics and investor confidence.
Regarding insider transactions, Chaim Indig, the CEO, sold 2,644 shares on July 16, 2024. Additionally, Hui Yvonne, the Principal Accounting Officer, sold 582 shares on June 10, 2025, under a Rule 10b5-1 trading plan. These actions are common and often related to tax obligations or compensation plans. Understanding these movements provides insights into the perspectives of key people within the firm.
| Metric | Details | Date |
|---|---|---|
| Total Revenue | $419.8 million | January 31, 2025 |
| Patient Visits Facilitated (2024) | Approximately 170 million | 2024 |
| Institutional Ownership | 95.32% | Q1 2025 |
Institutional investors continue to hold a significant stake in the company, with 456 institutional owners holding a total of 71,541,115 shares as of June 5, 2025. The institutional ownership percentage was 95.32% as of Q1 2025. The company has also made strategic acquisitions, like MediFind and Access eForms, which could affect ownership. The company is expanding its global operations, with operations expected to start in India during fiscal year 2025. To learn more about the company's target market, check out this article: Target Market of Phreesia.
Institutional investors hold a substantial portion of Phreesia shares, indicating strong confidence. The company's revenue has increased, showing growth and market presence. Recent acquisitions and global expansion plans highlight strategic initiatives.
Key executives have engaged in routine transactions, often related to tax obligations. These transactions provide insights into insider perspectives. Monitoring these activities can offer context to the company's financial health.
The company has made acquisitions like MediFind and Access eForms. These acquisitions can influence ownership. They can also impact financial performance and investor interest.
The company is expanding its global operations, including Phreesia India. The company's financial performance is growing, and the market is expanding. These developments could affect the company’s ownership structure.
Phreesia Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Phreesia Company?
- What is Competitive Landscape of Phreesia Company?
- What is Growth Strategy and Future Prospects of Phreesia Company?
- How Does Phreesia Company Work?
- What is Sales and Marketing Strategy of Phreesia Company?
- What is Brief History of Phreesia Company?
- What is Customer Demographics and Target Market of Phreesia Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.